Oorsprong van het eerstegraads netwerk van Stephen A. Moglia
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 20 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Stephen A. Moglia via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| MERCK & CO., INC. | Pharmaceuticals: Major | Sales & Marketing General Counsel Corporate Officer/Principal | |
Ascenta Therapeutics, Inc.
 Ascenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ascenta Therapeutics, Inc. engages in the discovery and development of medicines for cancer. Its core technology consists of agents designed to re-establish the natural program of apoptosis (cell death) in abnormal cancer cells. Its has three small molecule programs against distinct apoptosis targets: Bcl-2 (AT-101 – an oral pan-Bcl2 inhibitor), IAP (AT-406 – an oral multi-IAP inhibitor) and HDM2. The company was founded by Dajun Yang, Marc E. Lippman, and Shaomeng Wang on June 5, 2006 and is headquartered in Malvern, PA. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
| San Diego State University | College/University | Undergraduate Degree Undergraduate Degree | |
Nalpropion Pharmaceuticals, Inc.
 Nalpropion Pharmaceuticals, Inc. Managed Health CareHealth Services Nalpropion Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the treatment of weight loss. Its products include CONTRAVE, analtrexone HCl & bupropion HCl extended release and Mysimba, a naltrexone HCl/ bupropion HCl prolonged release. The company is headquartered in Morristown, NJ. | Managed Health Care | Director of Finance/CFO Compliance Officer | |
| EQUILLIUM, INC. | Biotechnology | Director/Board Member Director of Finance/CFO | |
| The Trustees of Columbia University in The City of New York | College/University | Graduate Degree Graduate Degree | |
PowerVision, Inc.
 PowerVision, Inc. Electronic ComponentsElectronic Technology PowerVision, Inc. develops fluid-controlled intraocular lens. The firm provides FluidVision accommodating intraocular lens technology, which restores the vision of youth to middle aged or elderly individuals affected by presbyopia and cataracts regain to adjust focus for clear vision at all distances. The company was founded by Matthew A. Frinzi, Randy McDonald, and Barry Cheskin in 2002 and is headquartered in Belmont, CA. | Electronic Components | Director/Board Member Chief Executive Officer | |
| PHASEBIO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
| METACRINE, INC. | Biotechnology | Chief Executive Officer Chief Executive Officer | |
BioVascular, Inc.
 BioVascular, Inc. Pharmaceuticals: MajorHealth Technology BioVascular, Inc. develops drugs and devices for control of intimal hyperplasia associated with vascular procedures. It is a integrated specialty cardiovascular therapeutic company, and to utilize corporate partnerships in markets that have complex marketing barriers and/or combination technologies. The company was founded by John H. Parrish and Paul F. Glidden in 2005 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Domain Associates LLC
 Domain Associates LLC Investment ManagersFinance Domain Associates LLC (Domain Associates) is a venture capital firm founded in 1985. The firm is headquartered in Princeton, New Jersey. | Investment Managers | Private Equity Investor Consultant / Advisor | |
US Food & Drug Administration
 US Food & Drug Administration General GovernmentGovernment US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD. | General Government | Corporate Officer/Principal | |
AstraZeneca LP
 AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Pharmaceuticals: Major | General Counsel | |
| Columbia University College of Physicians & Surgeons | College/University | Doctorate Degree | |
| Joseph L. Mailman School of Public Health | College/University | Graduate Degree | |
| FATE THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
| Columbia College (New York) | College/University | Undergraduate Degree | |
The American Society for Clinical Pharmacology & Therapeutics
 The American Society for Clinical Pharmacology & Therapeutics Miscellaneous Commercial ServicesCommercial Services The American Society for Clinical Pharmacology & Therapeutics is a scientific and professional organization that serves the disciplines of clinical pharmacology and translational medicine. The non-profit company is based in Alexandria, VA. The CEO of the company is Sharon Swan. | Miscellaneous Commercial Services | President | |
| KARYOPHARM THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
Alopexx Enterprises LLC
 Alopexx Enterprises LLC BiotechnologyHealth Technology Alopexx Enterprises LLC engages in investing and managing health care companies. It develops medical therapies and devices for infectious diseases, oncology, central nervous system, and orphan diseases. The firm commercializes an alternative for the treatment and prevention of staphylococcal and other bacterial infections and animal vaccines. The company was founded by Daniel R. Vlock, Deborah Ramsdell and Christine de los Reyes in 2011 and is headquartered in Concord, MA. | Biotechnology | Director/Board Member | |
Drug Information Association
 Drug Information Association Miscellaneous Commercial ServicesCommercial Services The Drug Information Association is a non-profit multidisciplinary association that operates to promote health and well-being. The non-profit company is based in Horsham, PA. Marwan Fathallah has been the CEO of the company since 2023. | Miscellaneous Commercial Services | Director/Board Member | |
Accelerating Therapeutics for Opportunities in Medicine
 Accelerating Therapeutics for Opportunities in Medicine Packaged SoftwareTechnology Services Accelerating Therapeutics for Opportunities in Medicine (ATOM) is an American company that focuses on molecular design and modeling programs. The private company works with open-source software and AMPL packages to build models and analyze data. The company collaborates with Lawrence Livermore National Laboratory scientists to fight against COVID-19 by combining artificial intelligence/machine learning, bioinformatics, and supercomputing to help discover drugs. ATOM shares updates about their new partners, technical team members, and presentations on their website. | Packaged Software | Director/Board Member | |
| HUMANIGEN, INC. | Biotechnology | Corporate Officer/Principal | |
| ALOPEXX, INC. | Biotechnology | Director/Board Member | |
| Medical Dictionary For Regulatory Activities | Corporate Officer/Principal | ||
| Center for Drug Evaluation & Research | General Government | Corporate Officer/Principal | |
Aerium Therapeutics, Inc.
 Aerium Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aerium Therapeutics, Inc. is an American biotechnology company that focuses on epidemic and pandemic preparedness. The company is based in Lausanne and has operations in the United States. The company's mission is to discover and develop antibodies and small molecule antivirals against SARS-CoV-2 and other epidemic and pandemic threats. Aerium Therapeutics has a team of world-class scientists and biotechnology veterans, as well as experienced investors. Aerium's lead assets are monoclonal antibodies that show broad activity against important variants of concern (VOCs) of SARS-CoV-2, including Omicron and its subvariants. The company plans to expand its pipeline to antiviral therapeutics in late 2022 and will broaden its focus to other epidemic and pandemic threats in the future. The CEO of the company is Rajeev Venkayya. | Miscellaneous Commercial Services | Director/Board Member | |
| AMGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
UCSF Medical Center
 UCSF Medical Center Hospital/Nursing ManagementHealth Services UCSF Medical Center owns and operates hospitals. It operates hospitals in San Francisco as well as satellite facilities. It provides health care facilities to children, organ transplants, cardiac care, fertility treatments, neurosurgery, ophthalmology, and orthopedics. It also provides outpatient care and some programs in areas as women's health, aging, cancer, and pain management. UCSF Medical Center is headquartered in San Francisco, CA. | Hospital/Nursing Management | Chief Tech/Sci/R&D Officer | |
| SANGAMO THERAPEUTICS, INC. | Biotechnology | Investor Relations Contact | |
| University College London | College/University | Undergraduate Degree | |
| ZELTIQ AESTHETICS INC | Medical Specialties | Director/Board Member | |
| CLOVIS ONCOLOGY, INC. | Pharmaceuticals: Major | Founder | |
| Lewis & Clark College (Oregon) | College/University | Director/Board Member | |
| FLEXION THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman | |
| Boulder Community Hospital | Director/Board Member | ||
| GRITSTONE BIO, INC. | Biotechnology | Chairman | |
Allergan Ltd.
 Allergan Ltd. Pharmaceuticals: MajorHealth Technology Allergan Ltd. provides eye care and specialty pharmaceutical products. It develops pharmaceutical products used for treatment of eye and skin care medications and neurological disorders. The firm develops products for glaucoma, dry eye, blepharospasm, cervical, dystonia, hemi-facial spasm, post-stroke spasticity and cerebral palsy. The company was founded in 1977 and is headquartered in Marlow, the United Kingdom. | Pharmaceuticals: Major | President |
Statistieken
Internationaal
| Verenigde Staten | 49 |
| Verenigd Koninkrijk | 3 |
Sectoraal
| Health Technology | 29 |
| Consumer Services | 9 |
| Commercial Services | 4 |
| Health Services | 3 |
| Finance | 3 |
Operationeel
| Director/Board Member | 130 |
| Corporate Officer/Principal | 47 |
| Independent Dir/Board Member | 44 |
| Chief Executive Officer | 33 |
| Chairman | 27 |
Sterkste connecties
| Insiders | |
|---|---|
| Eckard Weber | 46 |
| Brian H. Dovey | 40 |
| Louis C. Bock | 27 |
| Wendy Dixon | 25 |
| Deborah Jorn | 20 |
| Peter Honig | 20 |
| David Endicott | 18 |
| Preston Klassen | 15 |
| Patrick Mahaffy | 13 |
| Heather Ace | 9 |
| John Knighton | 9 |
| Michael York | 8 |
| Jason Keyes | 7 |
| Peter D. Flynn | 6 |
| McDavid Stilwell | 6 |
- Beurs
- Insiders
- Stephen A. Moglia
- Bedrijfsconnecties
